Affirmative LGBTQIA+ Care in Co-Occurring Treatment
This CE presentation reviews LGBTQIA+ history and its ongoing impact on mental health and substance use, while clarifying the difference between gender identity and sexual orientation. Participants will strengthen their ability to discuss LGBTQIA+ topics respectfully and apply affirmative practices to improve engagement and outcomes in co-occurring treatment settings. Less...
Learning Objectives
- Demonstrate knowledge of LGBTQIA+ history and the impact it has on the queer population's mental health and substance use.
- Explain differences in sexual orientation, gender identity and expression.
- Use affirming, inclusive, and clinically appropriate language when discussing LGBTQIA+ topics in therapeutic interactions.
- Demonstrate effective use of LGBTQIA+ affirmative language in therapeutic interactions.
Target Audience
This educational activity is intended for behavioral health professionals, including Psychologists, Social Workers, Counselors, and MFT's.
Learning Levels
- Beginner
- Intermediate
Friday, June 26, 2026
Live Interactive Webinar
11:00 AM CDT - 01:00 PM CDT
$10.00
EARN 2 CE Credit Hours
Click Here to Register
Click Here to Register
About the speakers
McKenzie Cargin, LADC-S
Clinical Development and Training Specialist
McKenzie Cargin, LADC-S, is the Clinical Development and Training Specialist at EOSIS and has 7 years of experience in MI/CD treatment. Previously, McKenzie was the Treatment Director at Latitudes specializing in LGBTQIA+ care for individuals with co-occurring disorders, Clinical Director at Beauterre Recovery Institute, and substance use counselor. As a member of the LGBTQIA+ community, McKenzie is passionate about working with individuals in the queer community and advocating for other marginalized communities who face barriers to accessing care.
Jac Clingerman, BA, LADC-S
Manager of Clinical Administration
Jac Clingerman, BA, LADC-S, is the Manager of Clinical Administration at EOSIS Tapestry & Latitudes and has 18 years of experience in substance use and co-occurring treatment. Jac’s background includes intervention and care coordination with A-I-R (Assistance in Recovery), providing MAT services at HCMC’s Addiction Medicine Clinic, and leadership roles at NUWAY, including Treatment Director for NUWAY III Women’s Residential Treatment Program. Jac specializes in working with underserved and marginalized communities, including women, LGBTQIA+ individuals, people with disabilities, individuals experiencing homelessness, and people with criminal justice involvement.
Agenda
11:00 to 11:05 Welcome and Housekeeping
11:05 to 11:10 Speaker Introduction
11:10 to 12:40 Presentation
12:40 to 1:00 Q and A
CE Information - Earn 2 CE Credit Hours
CE Approvals
Joint Accreditation
In support of improving patient care, CE Learning Systems is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Psychological Association
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP office maintains responsibility for the content of the programs.
New York Education Department's State Board for Social Work
CE Learning Systems, LLC (d/b/a impactce.com) is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed mental health counselors. #0060.
New York Education Department Board of Creative Arts Therapy
CE Learning Systems, LLC (d/b/a impactce.com) is recognized by the New York State Education Department's State Board of Creative Arts Therapy as an approved provider of continuing education for licensed mental health counselors. #CAT-0008
New York Education Department for Licensed Mental Health Counselors
CE Learning Systems, LLC (d/b/a impactce.com) is recognized by the New York State Education Department's State Board for Mental Health Practitioners as an approved provider of continuing education for licensed mental health counselors. #MHC-0072.
New York Education Department Board for Licensed Psychoanalysts
CE Learning Systems, LLC (d/b/a impactce.com) is recognized by the New York State Education Department's State Board for Psychoanalysts as an approved provider of continuing education for licensed mental health counselors. #P-0031.
New York State Education Department's State Board for Psychology
CE Learning Systems, LLC (d/b/a impactce.com) is recognized by the New York State Education Department's State Board for Psychology as an approved provider of continuing education for licensed mental health counselors. #PSY-0016.
New York Education Department's State Board for Marriage and Family Therapy
CE Learning Systems, LLC (d/b/a impactce.com) is recognized by the New York State Education Department's State Board for Marriage and Family Therapy as an approved provider of continuing education for licensed mental health counselors. #MFT-0045.
CE Process Info
Before the event, you will receive an email from CE-Go with access to the virtual event. After the event, you will receive access to your evaluation and continuing education certificate via a personalized "attendee dashboard" link, hosted on the CE-Go website. This link and access to the virtual event will be sent to the email account you used to register for the event.
Upon accessing the CE-Go "attendee dashboard", you will be able to:
- Complete evaluation forms for the event
- Download your continuing education certificate in a PDF format
If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at support@ce-go.com Please Note: Emails for this event will come from "support@ceactivities.com".
If you have any continuing education related questions, please contact your event organizer.
Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" support@ceactivities.com. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.
Disclosure
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSCE Learning Systems adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity ― including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The following relevant financial relationships have been disclosed by this activity’s planners, faculty, and the reviewer:
PLANNERS AND REVIEWER
The planners of this activity have reported that they have no relevant financial relationships.
FACULTY
Dr. <
Consultant - AbbVie, ANeuroTech (division of Anima BV), Signant Health, Magstim, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Sage, Silo Pharma, Engrail Therapeutics, Pasithea Therapeutic Corp., GoodCap Pharmaceuticals, Inc., Senseye, Clexio, Ninnion Therapeutics, EmbarkNeuro, SynapseBio, BioXcel Therapeutics, Relmada Therapeutics
Ownership Interest - Seattle Genetics, Antares, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, Naki Health, Relmada Therapeutics
Advisor - ANeuroTech (division of Anima BV), Brain and Behavior Research Foundation (BBRF), Anxiety and Depression Association of America (ADAA), Skyland Trail, Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Heading Health, Pasithea Therapeutic Corp., Sage
Executive Role - Gratitude America, ADAA, Lucy Scientific Discovery, Inc.
Royalty Or Patent Beneficiary - Method and devices for transdermal delivery of lithium (US 6,375,990B1) Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2)